Tumors implanted in K14-VEGFR3-Ig transgenic mice lacking dermal lymphatics due to the expression of a soluble VEGFR3 have impaired tumor antigen and dendritic cell trafficking to lymph nodes in addition to impaired anti-tumor immunity in response to dermal vaccine [81]. Here, FLT4 is linked to neoplasm.